Table 2.
Cancer treatment-related interventions and outcomes by duplicates.
| Not receiving any duplicate scan (N=33,611) |
Receiving at least one duplicate scan (N=2,680) |
|
|---|---|---|
|
Median(Q1–Q3) time from complete staging to first duplicate, days |
N/A | 4(1–14) |
|
Median(Q1–Q3) time from complete staging to first treatment, days |
9(3–20) | 17(7–35) |
|
Patients with a clinical evaluation between complete staging and first treatment1(%) |
26,564(79) | 1,930(72) |
| Median(Q1–Q3) number of evaluations |
2(2–4) | 4(2–6) |
|
Patients visiting the emergency department between complete staging and first treatment(%) |
3,587(11) | 788(29) |
| Median(Q1–Q3) number of visits | 1(1–1) | 1(1–1) |
| First treatment(%) | ||
| Surgery | 32,190(96) | 2,383(89) |
| Chemotherapy | 78(0) | 32(1) |
| Radiotherapy | 99(0) | 21(1) |
| No cancer-specific therapy | 1,244(4) | 244(9) |
| Months of follow-up | 1,885,882 | 119,649 |
| Number of deaths(%) | 18,296(54) | 1,697(63) |
| Number of colon cancer deaths(%) | 6,596(20) | 673(25) |
| Adjusted rate ratio for all cause mortality | Reference | 1.22(1.16–1.28) |
| Adjusted rate ratio for colon cancer mortality | Reference | 1.23(1.14–1.32) |
1
Clinical evaluation consists on any of the following: new outpatient, established outpatient, hospital observation services, new inpatient, established inpatient, observation/inpatient care services, outpatient consultation, inpatient consultation, follow-up inpatient consultation, confirmatory consultation, nursing facility services and team conference.